An adjuvant formulation containing Toll-like Receptor 7 agonist stimulates protection against morbidity and mortality due to Anaplasma marginale in a highly endemic region of west Africa.
Efficient cattle production and provision of animal-sourced foods in much of Africa is constrained by vector-borne bacterial and protozoal diseases.Effective vaccines are not currently available for most of these infections resulting in a continuous disease burden that limits genetic improvement.We tested whether stimulation of innate immunity usin